Dr. Reddy’s Wins Tentative FDA Approval for Yeztugo Generic
Photo: TokenPost
Dr. Reddy’s Laboratories said Monday that the U.S. Food and Drug Administration tentatively approved its generic targeting Yeztugo, Gilead Sciences’ twice-yearly HIV prevention medicine. Yeztugo is used for HIV prevention twice a year. The FDA action described by Dr. Reddy’s was tentative. Riza Dagoc reports on regulation, investing and the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
